![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 16 studies with search of: | "EntreMed" [Exact] |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
|
||||
2 | Active, not recruiting |
A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
|
||||
3 | Completed |
Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
|
||||
4 | Active, not recruiting |
Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
|
||||
5 | Completed |
Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
|
||||
6 | Active, not recruiting |
Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
|
||||
7 | Completed |
A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
|
||||
8 | Completed |
Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer
|
||||
9 | Completed |
Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
|
||||
10 | Completed |
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
|
||||
11 | Recruiting |
Phase 1 Study of MKC-1 in Patients With Advanced Cancer
|
||||
12 | Recruiting |
Study of ENMD-2076 in Patients With Multiple Myeloma
|
||||
13 | Recruiting |
A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
|
||||
14 | Completed |
A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
|
||||
15 | Completed |
Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer
|
||||
16 | Active, not recruiting |
A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
|